Bakhu Holdings Corp. engages in the production, manufacturing, and selling cannabis-related byproducts. The company is headquartered in Long Beach, California and currently employs 2 full-time employees. The company went IPO on 2009-06-22. The firm hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The firm is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. The company also intends to sublicense the Licensed Science to third party sub-licensees. The firm has not generated any revenue.

Industry: Patent Owners & Lessors Peers: Fulcrum Therapeutics Inc Ocular Therapeutix Inc Johnson & Johnson Liquidia Corp Phathom Pharmaceuticals Inc Rani Therapeutics Holdings Inc Provention Bio, Inc. Tarsus Pharmaceuticals Inc